在乳腺癌中进行男性信号和治疗向
Peng Liu1, Chaowen Shi1, Lipeng Qiu1
1School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China.
Current problems in cancer
|July 5, 2024
概括
患有多发性内分泌瘤1型 (MEN1) 的患者患乳腺癌的风险更高. 这次审查探讨了 menin menin 的情况.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 多发性内分泌新陈代谢1型 (MEN1) 与乳腺癌发生风险的增加有关.
- MEN1基因产物menin在乳腺癌信号通路中起着至关重要的作用.
研究的目的:
- 审查乳腺癌中menin的分子机制.
- 阐明明明因在基因转录和信号传递中的作用.
- 引导开发新的针对性乳腺癌治疗方法.
主要方法:
- 关于梅因在乳腺癌中的相互作用和功能的文献综述.
- 对敏的基因转录和DNA修复调节的分析.
- 检查梅因在诱导亡中的作用.
主要成果:
- 梅宁与多种蛋白质 (MLL,EZH2,JUND,NF-κB,PPARγ,VDR,Smad3,β-catenin,ERα) 相互作用,以抑制细胞增殖.
- 梅宁通过FANCD2相互作用增强BRCA1介导的DNA修复.
- 宫外阴膜表达诱导了细胞亡.
结论:
- 阴膜是乳腺癌发育和进展的关键调节剂.
- 了解menin的途径对于有针对性的乳腺癌药物开发至关重要.
- 对于乳腺癌治疗的门因抑制剂进行进一步的研究是有必要的.
更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.9K
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.3K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
